India's Jubilant Completes Acquisition of U.S. Co Hollister-Stier (India)
This article was originally published in PharmAsia News
Executive Summary
Jubilant Organosys, a pharmaceutical research company in India, has finalized the purchase of U.S.-based Hollister-Stier Laboratories for $122.5 million in an all-cash transaction. Jubilant is looking to strengthen its growing global expertise in custom-research and manufacturing services. (Click here for more
You may also be interested in...
Jubilant Profits Spurred By Foreign Business
Buoyed chiefly by earnings from its foreign businesses, India's pharmaceuticals and chemicals major Jubilant Organosys reported a net profit of 4 billion rupees ($98 million) for the year ending March 31
India’s Jubilant Organosys Nets $92 Million CRAMS Order For 2008
NEW DELHI - India's growing success in the pharmaceutical custom research and manufacturing services sector is demonstrated by Jubilant Organosys netting CRAMS contracts totaling $92 million for 2008, with most contracts coming from Japan, China, the U.S. and Europe, the Uttar Pradesh-based manufacturer said Feb. 2
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.